PRNewsWire - Health

NMPA Accepts NDA and Grants Priority Review Designation to Innovent's Ipilimumab Injection, China's First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer
PENN STATE THON™ RAISES $17.7 MILLION FOR CHILDHOOD CANCER, BREAKING ALL-TIME ANNUAL FUNDRAISING RECORD
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
Deerfield Management Announces Collaboration with QIA as Part of its Fund of Funds VC Program and the Opening of a Regional Office in Doha